17 completed, 2 terminated, 1 unknown. 20 Phase 2, 4 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 20 | Completed 17, Terminated 2, Unknown 1 |
| Phase 1 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 3 | 3 | Completed 3 |
Follow Colonoscopy: new trials by email Literature Review of Colonoscopy trials Research Report on Colonoscopy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy ET-26HCl 0.6mg/kg group, ET-26HCl 0.8mg/kg group, Etomidate Injectable Product 0.3mg/kg group - Gastroscopy, Colonoscopy | Phase 2 | Completed | Ahon Pharmaceutical Co., Ltd. | 78 | 2024-11-15 | 2025-05-25 |
| Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic Polypectomy Glycopyrrolate, Placebo - Glycopyrrolate, Colonoscopy | Phase 1 / Phase 2 | Unknown | Jie Chen | 150 | 2023-10-08 | 2023-12-08 |
| The Change of Gut Microbiota After Bowel Preparation and the Effect of Probiotics Duolac - Gut Microbiota, Bowel Preparation | Phase 2 | Completed | Kosin University Gospel Hospital | 100 | 2018-12-01 | 2020-02-20 |
| A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects BLI4900, PEG Control - Colonoscopy | Phase 2 | Completed | Braintree Laboratories | 121 | 2017-11-09 | 2023-10-24 |
| BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects BLI4700 - Colonoscopy | Phase 2 | Completed | Braintree Laboratories | 17 | 2017-02-16 | 2023-11-15 |
| A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients HSK3486, Propofol - Colonoscopy | Phase 2 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 64 | 2016-12-01 | 2018-12-13 |
| A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects BLI4700 - Colonoscopy | Phase 1 / Phase 2 | Completed | Braintree Laboratories | 120 | 2016-08-01 | 2023-11-15 |
| Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy ABP-700 - Colonoscopy | Phase 2 | Completed | The Medicines Company | 150 | 2016-05-01 | 2018-02-20 |
| Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy BLI800 - Dose 1, BLI800 - Dose 2 - Colonoscopy | Phase 2 | Completed | Braintree Laboratories | 29 | 2014-06-01 | 2021-03-15 |
| Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults Crystalline Lactulose - Colonoscopy | Phase 2 | Completed | Benaroya Research Institute | 40 | 2012-07-01 | 2014-08-08 |
| Measurement of Gastric Emptying During and After COLOKIT® Intake Sodium phosphate - Colonoscopy | Phase 2 | Completed | Laboratoires Mayoly Spindler | 30 | 2011-10-01 | 2012-11-29 |
| Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen PillCam® COLON 2 procedure using MgC boosts, PillCam® COLON 2 procedure using Suprep boosts, PillCam® COLON 2 procedure using reduced dose of Suprep boosts - Colonoscopy, Endoscopy | Phase 2 / Phase 3 | Completed | Medtronic - MITG | 80 | 2010-07-01 | 2019-07-31 |
| Can Simple and Inexpensive Techniques Enhance Patient Comfort Colonoscopy - Colonoscopy | Phase 1 / Phase 2 | Terminated | VA Office of Research and Development | 82 | 2007-12-01 | 2017-04-21 |
| An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters BLI-800 - Colonoscopy, Bowel Preparation | Phase 1 / Phase 2 | Completed | Braintree Laboratories | 18 | 2007-08-01 | 2010-11-11 |
| PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy PEG (solution given 4 L), senna glycoside 36 mg and PEG (solution given 2 L) - Colonoscopy | Phase 2 / Phase 3 | Completed | Umeå University | 490 | 2005-09-01 | 2011-03-24 |
| MOVIPREP® Versus PICOLAX® Pilot Study macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate, NA picosulfate magnesium citrate - Colonoscopy | Phase 2 | Completed | Norgine | 65 | 2005-07-01 | 2007-12-17 |
| Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy AQUAVAN® (fospropofol disodium) Injection, Midazolam HCl - Colonoscopy, Colonic Polyps | Phase 2 / Phase 3 | Completed | Eisai Inc. | 125 | 2005-07-01 | 2008-11-07 |
| A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy fospropofol disodium - Colonoscopy, Colon Polyps | Phase 2 | Terminated | Eisai Inc. | 100 | 2005-02-01 | 2023-06-18 |
| A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy fospropofol disodium - Colonoscopy, Colon Polyps | Phase 2 | Completed | Eisai Inc. | 200 | 2003-01-01 | 2009-12-04 |
| Clinical Evaluation of a New Reduced Volume Bowel Preparation macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate - Colonoscopy | Phase 2 | Completed | Norgine | 30 | 2001-01-01 | 2008-04-16 |
Colonic Polyps (3)
Intestinal Polyps (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Polyps (3)
fospropofol (3) · Colonoscopy (1) · ET-26 compound (1) · Glycopyrrolate (1) · HSK3486 (1) · Injections (1) · Midazolam (1) · MoviPrep (1) · Population Groups (1) · Propofol (1) · Sennosides (1) · abp-700 (1) · sodium phosphate (1)
Braintree Laboratories (5) · Eisai Inc. (3) · Norgine (2) · Ahon Pharmaceutical Co., Ltd. (1) · Benaroya Research Institute (1) · Jie Chen (1) · Kosin University Gospel Hospital (1) · Laboratoires Mayoly Spindler (1) · Medtronic - MITG (1) · Sichuan Haisco Pharmaceutical Group Co., Ltd (1) · The Medicines Company (1) · Umeå University (1) · VA Office of Research and Development (1)
United States (9) · China (3) · France (2) · Netherlands (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
John McGowan, MPH (3) · James Jones, MD,PharmD (2) · A.R. Absalom, MD (1) · Alain Bitoun, MD (1) · Douglas Rex, Prof. (1) · Felix W Leung, MD (1) · Guangyou Duan, doctor (1) · James Jones, PharmD, MD (1) · Markku M Haapamaki, MD, PhD (1) · Mengchang Yang (1) · Mike Geraint, MD (1) · Otto Lin, MD (1) · Peter Naredi, MD, PhD (1) · Russell Pelham, Ph.D. (1)
PMID 18179734, PMID 20619405, PMID 20812020, PMID 25309090, PMID 38082231
2015 (1)